Jan Skvarka serves as Executive at Trillium Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Jan Skvarka has executed 13 insider transactions totaling $1.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 21, 2024 involved receiving (via award) 41,581 shares valued at $0.
Jan Skvarka currently holds 89,551 shares of Trillium Therapeutics Inc. (TRIL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jan Skvarka has been a net seller of TRIL stock. They have purchased $0 and sold $1.7M worth of shares.
Jan Skvarka's most recent insider trade was on Jun 21, 2024, when they sold 41,581 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $25.05 |
| Planned |
| Jun 16, 2023 | ZNTL | $0 | Award | 16,364 | $N/A | Discretionary |
| Sep 9, 2022 | ZNTL | $0 | Award | 36,606 | $N/A | Discretionary |
| May 12, 2021 | TRIL | $7.4K | Option Exercise | 23,802 | $0.31 | Discretionary |
| May 12, 2021 | TRIL | $219.9K | Sale | 23,802 | $9.24 | Discretionary |
| May 11, 2021 | TRIL | $39.4K | Option Exercise | 87,500 | $0.45 | Discretionary |
| May 11, 2021 | TRIL | $6.0K | Option Exercise | 19,198 | $0.31 | Discretionary |
| May 11, 2021 | TRIL | $981.6K | Sale | 106,698 | $9.20 | Discretionary |
| Jan 14, 2021 | TRIL | $294.3K | Sale | 19,581 | $15.03 | Discretionary |
| Jan 14, 2021 | TRIL | $8.4K | Option Exercise | 19,581 | $0.43 | Discretionary |
| Jan 13, 2021 | TRIL | $2.3K | Option Exercise | 5,419 | $0.42 | Discretionary |
| Jan 13, 2021 | TRIL | $81.5K | Sale | 5,419 | $15.04 | Discretionary |